The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis.
<h4>Introduction</h4>Before anti-EGFR therapy is given to patients with colorectal cancer, it is required to determine KRAS mutation status in tumor. When tumor tissue is not available, cell-free DNA (liquid biopsy) is commonly used as an alternative. Due to the low abundance of tumor-de...
Main Authors: | Peng Ye, Peiling Cai, Jing Xie, Yuanyuan Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248775 |
Similar Items
-
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
by: Maria Palmieri, et al.
Published: (2022-10-01) -
Diagnostic Accuracy of Droplet Digital PCR and Amplification Refractory Mutation System PCR for Detecting EGFR Mutation in Cell-Free DNA of Lung Cancer: A Meta-Analysis
by: Caichen Li, et al.
Published: (2020-03-01) -
Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01) -
KRAS and TP53 mutations in colorectal carcinoma
by: Al-Kuraya Khawla
Published: (2009-01-01) -
Detection of KRAS mutations of colorectal cancer with peptide-nucleic-acid-mediated real-time PCR clamping
by: Xihong Zhao, et al.
Published: (2016-11-01)